[Carcinogenicity and biological effectiveness of sterigmatocystin].
Zhang
Xiang-hong
XH
zhangxianghong2008@163.com
Xue
Li-ying
LY
D000230:Adenocarcinoma / Q000139:chemically induced* / Q000378:metabolism; D000818:Animals; D017209:Apoptosis / Q000187:drug effects; D002273:Carcinogens / Q000633:toxicity*; D015395:Histocompatibility Antigens Class I / Q000378:metabolism; D006801:Humans; D007371:Interferon-gamma / Q000378:metabolism; D007376:Interleukin-2 / Q000378:metabolism; D008175:Lung Neoplasms / Q000139:chemically induced* / Q000378:metabolism; D008214:Lymphocytes / Q000166:cytology / Q000378:metabolism; D037721:Pulmonary Surfactant-Associated Protein C / Q000378:metabolism; D013241:Sterigmatocystin / Q000633:toxicity*
D002273:Carcinogens; D015395:Histocompatibility Antigens Class I; D007376:Interleukin-2; D037721:Pulmonary Surfactant-Associated Protein C; D013241:Sterigmatocystin; D007371:Interferon-gamma